Cancer Type/Condition: Lymphoma, Hodgkin lymphoma, child
Stage/Subtype: stage I childhood Hodgkin lymphoma
Country: U.S.A.
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: MSKCC-95024, NCI-V95-0685, NCT00002663
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 0 to 55
Sponsor: Other
Protocol IDs: 8717, NCT00673114
|
|
4.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 74
Sponsor: NCI
Protocol IDs: 080051, 08-C-0051, NCT00923910
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD99, NCT00145600
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: NCI
Protocol IDs: UMN-2005LS048, UMN-0508M72589, UMN-MT2004-24, NCT00345865
|
|
7.
|
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD05, NCT00352027
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 70 years old and under
Sponsor: NCI
Protocol IDs: CCCWFU-29506, CCCWFU 29506, NCT00453206, CCCWFU-IRB00001366
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: CINJ-3330, NCT00161187
|
|
10.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 2 and over
Sponsor: NCI
Protocol IDs: CHNMC-06141, 06141, NCT00589563
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 11300A, NCT00683046
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: BMTGG-NSH-756, NSH 756, NCT00818961
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD08, NCT00846742
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: UFPTI 0806 - HL01, NCT00850200
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 70
Sponsor: NCI, NHLBI
Protocol IDs: 606, U01 HL069294, NCT00864227
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P2 L-D AB, NCT00917826
|
|
17.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCT01010217
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: BCM-H-9936-ALCI, H 9936, NCT00671164
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 22899, NCT00709033
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: VU-VICC-PED-0711, VICCPED0711, VU-VICC-070233, EUSA-VU-VICC-PED-0711, NCT00590915
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: COG-AHOD03P1, AHOD03P1, NCT00107198
|
